virus
-

Details emerge of first Huntingtonās disease gene therapy clinical trial
UniQure announces key details of its planned trial to assess the safety and ability of AMT-130 gene therapy to lower the problematic huntingtin protein using a āsingle-shotā virus delivery system.

